Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depression

被引:97
作者
Kasper, Siegfried [2 ]
Caraci, Filippo [1 ]
Forti, Bruno [3 ]
Drago, Filippo [1 ]
Aguglia, Eugenio [4 ]
机构
[1] Univ Catania, Dept Expt & Clin Pharmacol, Sch Med, I-95125 Catania, Italy
[2] Med Univ Wien, Dept Gen Psychiat, Muv, Austria
[3] CSM, Belluno, Italy
[4] Univ Catania, Dept Clin Psychiat, Sch Med, I-95125 Catania, Italy
关键词
Depression; Hypericum; St. John's wort; Efficacy; Review; ST-JOHNS-WORT; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; TERM MAINTENANCE TREATMENT; HEALTHY MALE-VOLUNTEERS; ONCE-DAILY DOSAGE; DOUBLE-BLIND; MAJOR DEPRESSION; CLINICAL-TRIALS; ANTIDEPRESSANT COMPLIANCE;
D O I
10.1016/j.euroneuro.2010.07.005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Depression is a common condition in the community with a significant impact on affected individuals, their relatives and society. Many patients with depression do not seek treatment and are often concerned about the possible adverse effects of antidepressant drugs. Extract of Hypericum perforatum (St. John's wort) has long been recognized as a treatment for depression. Several published trials and meta-analyses have demonstrated the efficacy and tolerability of Hypericum extract for mild to moderate depression. Recent comparative trials of Hypericum extract and other antidepressants, including, selective serotonin reuptake inhibitors (SSRIs), provide support for Hypericum extract efficacy. However, since the constituents of Hypericum extract differ between the individual manufacturers, the efficacy cannot be extrapolated from one extract to another. In this review, WS 5572, LI 160, WS 5570 and ZE 117 Hypericum extracts have been shown to be significantly more effective than placebo with at least similar efficacy and better tolerability compared to standard anti depressant drugs. (C) 2010 Elsevier B.V. and ECNP. All rights reserved.
引用
收藏
页码:747 / 765
页数:19
相关论文
共 116 条
  • [1] AGUGLIA E, 2001, DEPRESSIONE NORMALIT
  • [2] Depression in the Italian community: epidemiology and socio-economic implications
    Battaglia, A
    Dubini, A
    Mannheimer, R
    Pancheri, P
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (03) : 135 - 142
  • [3] Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression
    Behnke, K
    Jensen, GS
    Graubaum, HJ
    Gruenwald, J
    [J]. ADVANCES IN THERAPY, 2002, 19 (01) : 43 - 52
  • [4] BERGMANN R, 1993, THERAPIEWOCHE NEUROL, V7, P235
  • [5] Hypericum extract LI 160 and fluoxetine in mild to moderate depression - A randomized, placebo-controlled multi-center study in outpatients
    Bjerkenstedt, L
    Edman, GV
    Alken, RG
    Mannel, M
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2005, 255 (01) : 40 - 47
  • [6] Acute neuropathy after exposure to sun in a patient treated with St John's Wort
    Bove, GM
    [J]. LANCET, 1998, 352 (9134) : 1121 - 1122
  • [7] Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: A double-blind, randomized pilot study
    Brenner, R
    Azbel, V
    Madhusoodanan, S
    Pawlowska, M
    [J]. CLINICAL THERAPEUTICS, 2000, 22 (04) : 411 - 419
  • [8] Hypericin and pseudohypericin: Pharmacokinetics and effects on photosensitivity in humans
    Brockmoller, J
    Reum, T
    Bauer, S
    Kerb, R
    Hubner, WD
    Roots, I
    [J]. PHARMACOPSYCHIATRY, 1997, 30 : 94 - 101
  • [9] Mechanism of action of St John's wort in depression - What is known?
    Butterweck, V
    [J]. CNS DRUGS, 2003, 17 (08) : 539 - 562
  • [10] Butterweck V, 2007, WIEN MED WOCHENSCHR, V157, P356, DOI 10.1007/s10354-007-0440-8